Monthly Prescribing Reference

Gonal-f RFF Redi-ject Now Available

EMD Serono announced that Gonal-f RFF Redi-ject (recombinant follitropin alfa), a disposable prefilled drug injector pen intended for subcutaneous injection of a liquid formulation of Gonal-f RFF ...
Monthly Prescribing Reference

FDA Approves New Version of Gonal-f Prefilled Pen

GONAL-f (follitropin alfa injection) is a recombinant human follicle-stimulating hormone (r-hFSH) approved for the treatment female infertility and a rare form of male infertility. Merck announced ...
FierceBiotech

Merck Serono Received European Approval for Three Pre-filled, Ready-To-Use Pen Injectors for Fertility Treatment

GENEVA, July 4, 2011 /PRNewswire/ -- Merck Serono, a division of Merck KGaA, Darmstadt, Germany, today announced that the European Commission (EC) has granted an approval for three pre-filled, ...
Business Wire

EMD Serono Receives FDA Approval for Redesigned Fertility Pen

The Gonal-f ® RFF Redi-ject™ will be available in December 2013 in three pen sizes: 300 IU, 450 IU and 900 IU. For more information about the Gonal-f ® RFF Redi-ject™, please call Fertility Lifelines ...
EurekAlert!

Serono receives FDA approval for Gonal-f RFF Pen to treat infertility

Geneva, Switzerland and Rockland, MA, May 27, 2004 -- Serono, Inc., the US affiliate of Serono (virt-x: SEO and NYSE: SRA), announced today that the United States Food and Drug Administration (FDA) ...